Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
accuracy, afford, airplane, Alto, ampul, attack, attrition, AutoNation, background, barred, bidder, binding, black, Bondholder, bore, box, British, Bronzewood, Butcher, caffeine, Canadian, carrier, Cedar, CEO, chain, chapter, checklist, clearance, closure, compel, complicate, concealment, consensual, consumption, contempt, coordinated, COSO, counterclaim, County, curtail, Czajkowski, Czajkowskijoined, deadline, deteriorate, deteriorated, developmental, DIP, discovered, dismissed, diversification, divisional, downturn, driven, DSM, earliest, economy, equitable, eviction, excise, explanatory, forward, framework, fraudulent, fullest, gauge, Generale, Georgejoined, Harrington, Harringtonjoined, heart, Hennepin, highlight, hoc, hope, HR, immaterial, inaccurate, incapacity, ineffective, input, insider, inter, intestinal, intrinsic, irresolvable, jeopardize, journal, lab, landlord, lessor, lived, log, logistical, lowest, Ludo, Lynxorb, MA, mandatory, manual, Marlborough, Matthew, maximize, memoranda, MGI, Michael, Minnesota, misrepresentation, Monday, MVI, nominal, nonclinical, Northern, NSAID, optionee, ordinary, outlined, overpayment, Overview, Oxley, Palladium, Palo, pari, parity, passu, paydown, Pennock, perspective, Petroleum, Ph, PharmaBio, pharmacovigilance, Pink, pneumonia, post, posted, posting, POZEN, prejudice, preliminary, prepay, privilege, procedure, profile, proper, protocol, prudence, ratify, rationalize, reacquire, reacquired, reacquisition, reborrow, reborrowed, recoup, relinquished, remote, reorganization, reorganized, rescind, residual, retesting, Road, Robert, roll, Rothschild, sanction, satisfactory, setoff, settlement, shift, sicor, Singer, situation, Societe, Sonoco, speed, straight, stroke, strongest, sublease, sued, Superior, Supplementary, suspected, Syntex, task, tasked, thereon, tract, Transnational, Treadway, trustee, tuition, unauthorized, uncured, undertook, underway, undrawn, unpaid, unqualified, unreserved, unrevoked, untimely, UROCOR, Wachovia, warranted, weekly, Wheat, wholly, worksite
Removed:
Abbott, abreast, administering, agonist, air, albuterol, alternate, ampoule, analyze, begun, bone, bronchial, bronchodilator, Brunswick, Calcijex, certified, cetan, check, chemically, combine, composition, computer, confidential, consecutive, continuation, convenience, creation, daily, delinquent, depth, detailing, diversify, employer, enhancement, estradiol, exclusively, expiring, extending, facing, favorably, gastrointestinal, geriatric, Hectorol, hold, host, immunosuppression, incorrect, indexing, Institute, invest, investor, Italy, lung, mark, materialize, meaningful, morale, pediatric, people, piece, preceding, premature, premium, prescribe, promising, proxy, quick, removal, rheumatoid, ryan, scanning, selectively, side, slightly, softgel, strongly, suffering, taste, terbutaline, treble, Ultram, unknown, upgrading, validated, Zemplar
Filing tables
Filing exhibits
Related press release
Aaipharma similar filings
Filing view
External links
Exhibit 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| (1) | Registration Statement (Form S-1 No. 333-85602) of aaiPharma Inc., and | |||
| (2) | Registration Statements (Form S-8 Nos. 333-89020, 333-78453, 333-50877, 333-74515, 333-67114, and 333-50841) pertaining to the various stock option and employee benefit plans of aaiPharma Inc.; | |||
of our report dated April 26, 2005, with respect to the consolidated financial statements and schedule of aaiPharma Inc. included herein (which contains an explanatory paragraph that describes conditions that raise substantial doubt about the Company’s ability to continue as a going concern as described in Note 1 to the consolidated financial statements) and our report dated April 26, 2005, with respect to aaiPharma Inc. management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting of aaiPharma Inc. included herein.
| /s/ Ernst & Young LLP |
Raleigh, North Carolina
April 27, 2005
202